Loading…
Vaishali Pharma (VAISHALI)₹7.02+1.01%Pharmaceuticals
Vaishali Pharma is compared with the 10 closest in size in Pharmaceuticals (229 companies in the industry). It has a P/E of 23.4 against a peer median of 22.3, and ROCE of 7.9% against a peer median of 7.9%. By market cap it is #4 of 11 in this set.
As of · Peer set: 10 closest in size in Pharmaceuticals
| Company | M-cap (₹ Cr) | P/E | ROCE % | ROE % | Debt / equity | Div. yield % | Sales (₹ Cr) | Net profit (₹ Cr) | Qtr sales growth % | Qtr profit growth % | Compare |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Veerhealth Care | 103 | 177.3 | 7.2 | 3.0 | 0.20 | 0.0 | 33 | 1 | 198.0 | — | vs VAISHALI |
| Concord Drugs | 96 | 44.3 | 5.5 | 2.6 | 0.28 | 0.0 | 79 | 1 | 53.9 | 900.0 | vs VAISHALI |
| Cian Healthcare | 94 | — | −16.1 | −49.2 | 3.38 | 0.0 | 28 | −23 | 41.6 | — | vs VAISHALI |
| Vaishali Pharma | 91 | 23.4 | 7.9 | 6.0 | 0.28 | 0.0 | 109 | 4 | — | — | — |
| Mercury Laboratories | 88 | 21.2 | 12.1 | 9.1 | 0.14 | 0.5 | 76 | 5 | −12.0 | −69.8 | vs VAISHALI |
| Amwill Health Care | 87 | 7.6 | 21.1 | 15.4 | 0.00 | 1.2 | 43 | 11 | 41.1 | 100.0 | vs VAISHALI |
| Jfl Life Sciences | 85 | 13.0 | 18.0 | 15.0 | 0.47 | 0.0 | 131 | 6 | −4.2 | 48.6 | vs VAISHALI |
| Denis Chem Lab | 83 | 10.0 | 14.0 | 9.6 | 0.05 | 2.5 | 182 | 8 | 13.1 | −43.1 | vs VAISHALI |
| Vilin Bio Med | 83 | 43.3 | 10.8 | 7.5 | 0.01 | 0.0 | 42 | 2 | 215.6 | 1,866.7 | vs VAISHALI |
| Rekvina Labs | 81 | — | −333.3 | — | — | 0.0 | 1 | −0 | — | — | vs VAISHALI |
| Samrat Pharmachem | 80 | — | −3.0 | −4.8 | 0.16 | 0.4 | 289 | −3 | 0.7 | — | vs VAISHALI |
| Peer median | 87 | 22.3 | 7.9 | 6.7 | 0.18 | 0.0 | 76 | 2 | 41.1 | 74.3 |
Listed companies closest to Vaishali Pharma in Pharmaceuticals include Veerhealth Care, Concord Drugs, Cian Healthcare, Mercury Laboratories, Amwill Health Care, Jfl Life Sciences, Denis Chem Lab, Vilin Bio Med.
Veerhealth Care, with a market cap of ₹103 Cr.
Vaishali Pharma trades at a P/E of 23.4; the median of its peer set is 22.3. A P/E above or below the median is a description, not a judgement on value.
Vaishali Pharma's return on capital employed is 7.9%, above the peer median of 7.9%.